Syncromune® Inc. Expands Scientific Advisory Board with Addition of Prominent Oncology Trailblazer James Armitage, M.D.Dr. Armitage is a world-renowned expert in the research and treatment of lymphoma and will serve as Advisory Board ChairOctober 31, 2023 08:00 AM Eastern Daylight Time FORT LAUDERDALE, Fla.--(BUSINESS WIRE)--Syncromune®, Inc., a clinical-stage biopharmaceutical company focused on...
